Welcome to the website of the Cochrane Incontinence Group.
Our aim is to prepare, maintain and disseminate systematic reviews of the effectiveness of interventions for incontinence, including prevention, treatment and rehabilitation, concentrating on randomised controlled trials.
Cochrane Incontinence is one of the Cochrane review groups, an international organisation dedicated to informing those who provide or receive health care on the best available evidence.
Exploratory meeting held on 25 June 1995
Registered with the Cochrane on 10 June 1996
The group was originally known as CURE (Cochrane group for urinary and faecal incontinence)
Cochrane is an international not-for-profit organisation, providing up-to-date information about the effects of health care. We produce the Cochrane Database of Systematic Reviews, part of the Cochrane Library, the definitive resource for evidence-based health care.
Cochrane is an independent, international non-profit organisation, dedicated to making up-to-date, accurate information about the effects of healthcare readily available worldwide. It produces and disseminates systematic reviews of healthcare interventions and promotes the search for evidence in the form of clinical trials and other studies of interventions. Cochrane was founded in 1993 and named for the British epidemiologist, Archie Cochrane.
The major product of Cochrane is the Cochrane Database of Systematic Reviews which is published monthly as part of the Cochrane Library.
Those who prepare the reviews are mostly health care professionals who volunteer to work in one of the many Cochrane review groups, with editorial teams overseeing the preparation and maintenance of the reviews, as well as application of the rigorous quality standards for which Cochrane Reviews have become known.
The activities of the Cochrane are directed by an elected Steering Group and are supported by staff in Cochrane Entities (Centres, Review Groups, Methods Groups, Fields/Networks) around the world.
Learn even more about the structure, organization, and products of the Cochrane.
Scope of our reviews
The focus of the Cochrane Incontinence Group is interventions designed to prevent or treat incontinence, or aid rehabilitation. The problems covered include urinary or faecal incontinence; enterocutaneous or enterovesical fistulae; enuresis; day-time wetting in children; encopresis; post prostatectomy stress incontinence; use of urinary catheters including catheter-related urinary tract infections (but not other urinary infections); neurogenic incontinence and retention; post operative urinary retention; and rectal or vaginal prolapse.
The Group will concentrate on interventions when incontinence is the primary problem. For example, whereas the management of post-prostatectomy incontinence does come within the group's remit, incontinence as one of a number of symptoms of prostatic disease does not, nor does constipation or diarrhoea due to gastrointestinal disease or infection. Management of vaginal and rectal prolapse, with and without incontinence, will be covered, however.
We will predominantly use evidence from randomised or quasi-randomised controlled trials for evaluating relevant health care interventions.
Some reviews consider the management of incontinence in groups of people characterised by an underlying condition. Examples are incontinence after stroke, or associated with multiple sclerosis or spinal cord injury, and enuresis due to delayed childhood development. In these cases the Cochrane Incontinence Group shares editorial responsibility with the Review group that is covering the underlying condition.
The Editorial Base of the Cochrane Incontinence Group is based within the University of Aberdeen, UK
Editorial Base Staff:
Luke Vale, Newcastle upon Tyne, UK
Cochrane Information Specialist
Sheila Wallace, Aberdeen, UK
Brian Buckley, Eire, Ireland
Jonathan Cook, Oxford, UK
Nicola Dean, York, UK
Aniruddh V Deshpande, Newcastle, Australia
Chantale Dumoulin, Montréal, Canada
Suzanne Hagen, Glasgow, UK
Jean Hay-Smith, Dunedin, New Zealand
Peter Herbison, Dunedin, New Zealand
Priya Madhuvrata, Sheffield, UK
Catherine Murphy, Southampton, UK
Joseph Ogah, Cumbria, UK
Joan Ostaszkiewicz, Burwood Victoria, Australia
Rob Pickard, Newton upon Tyne, UK
Shaun Treweek, Aberdeen, UK
Sheila Wallace, Aberdeen, UK
Kate Williams, Leicester, UK
Funding and support
The Cochrane Incontinence Group is part of Cochrane, an independent not-for-profit consortium dedicated to providing up-to-date, accurate information about the effects of health care. The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Incontinence Group.
Cochrane central functions are funded by royalties from its publishers, John Wiley and Sons Limited, which come from sales of subscriptions to the Cochrane Library. The individual entities of Cochrane are funded by a large variety of governmental, institutional and private funding sources, and are bound by organisation-wide policy limiting uses of funds from corporate sponsors. Please visit our funders page here for a list of our funders.